Lv5
1270 积分 2021-03-26 加入
The “Quiet TED”—A Special Subgroup of Thyroid Eye Disease
1个月前
已关闭
Progress in study on the Molecular mechanism of age-related thymic involution
3个月前
已完结
Research progress of Notch signaling pathway and thymic development and regeneration
3个月前
已完结
Teprotumumab Related Hearing Loss: A Large-Scale Analysis and Review of Voluntarily Reported Patient Complaints to the Food and Drug Administration (FDA)
7个月前
已完结
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials
7个月前
已完结
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials
8个月前
已完结
A dose finding, safety and pharmacokinetic study of AVE1642, an anti-insulin-like growth factor-1 receptor (IGF-1R/CD221) monoclonal antibody, administered as a single agent and in combination with docetaxel in patients with advanced solid tumours
8个月前
已完结
Phase I Study of AVE1642 Anti IGF-1R Monoclonal Antibody in Patients with Advanced Multiple Myeloma
8个月前
已完结
Phase I Study of AVE1642 Anti IGF-1R Monoclonal Antibody in Patients with Advanced Multiple Myeloma
8个月前
已关闭
皖公网安备34019202002308
